Rodd, Zachary A. http://orcid.org/0000-0002-8105-1920
Hauser, Sheketha R.
Swartzwelder, H. Scott
Waeiss, R. Aaron
Lahiri, Debomoy K.
Bell, Richard L.
Funding for this research was provided by:
National Institute on Alcohol Abuse and Alcoholism (AA20908, AA07611, AA07462, AA10721)
National Institute on Alcohol Abuse and Alcoholism (AA019366)
National Institute on Aging (AG051086)
Article History
Received: 7 November 2019
Accepted: 18 May 2020
First Online: 30 June 2020
Compliance with ethical standards
:
: DKL is a member of the advisory boards for Entia Biosciences, Drug Discovery and Therapy World Congress, and Provaidya LLC. He also has stock options from QR Pharma for patents or patents pending on AIT-082, Memantine, Acamprosate, and GILZ analogs. DKL is the Editor-in-Chief of the journal “Current Alzheimer Research.” DKL also had prior funding from Baxter and Forest Research Labs. All have no direct influence on the research presented here. Finally, DKL declares no other actual or potential competing interests in the subject matter of this paper. ZAR, SRH, RAW, and RLB have used the current data set to apply for a provisional patent titled “The use of alpha-7 nicotinic receptor negative allosteric modulators for the prevention of adolescent alcohol consumption producing alcohol use disorder (AUD) and drug addiction during adulthood” with the US and EU patent office.